Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Synthomer Plc Fiscal Year Pretax Profit Rises - Quick Facts

Synthomer plc (SYNT.L) reported pretax profit of 59.1 million pounds for the year ended 31 December 2013, compared to 58.8 million pounds, last year. Profit attributable to equity holders of the parent declined 48.3 million pounds or 14.1 pence per share, from 53.1 million pounds or 15.4 pence per share, previous year.

Underlying pretax profit declined to 90.1 million pounds, from 94.6 million pounds. Underlying earnings per share was 20.5 pence, compared to 20.6 pence, a year ago.

Total sales were 1.05 billion pounds, compared to 1.11 billion pounds, last year. Group revenue declined to 992.7 million pounds, from 1.05 billion pounds.

The Board of Synthomer has recommended an increased final dividend of 3.6 pence per share, making a total dividend for the year of 6.0 pence. The full year dividend of 6.0 pence represents an increase of 9.1% over the previous year.

Click here to receive FREE breaking news email alerts for Synthomer Plc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office. After coming under pressure in early trading, stocks have seen some further downside over the course of the trading day on Friday. With the losses on the day, the S&P 500 is pulling back well off the record closing high that it set in the previous session.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.